• S&P 500: 1,351.95
  • Change: 0.15%
$17.05 0.58 (+3.52%)
2/9/2012 4:00 PM

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Current Price $17.05 Mkt Cap $2.49B
Open $0.00 P/E Ratio 0.00
Prev. Close $16.47 Div. (Yield) N/A (N/A)
Daily Range $15.60 - $17.10 Volume 5,447,796
52-Wk Range $8.03 - $18.30 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think AMLN will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

408 Outperform
58 Underperform
 

All-Star Players

116 Outperform
16 Underperform
 

Wall Street

15 Outperform
7 Underperform
 

Top AMLN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

geomedf (61.34)
Submitted January 27, 2012

Succeeded in their third attempt to gain U.S. clearance for Bydureon, a once-weekly version of Amylin’s diabetes shot.

Add Comment | Reply | Report this Post

Dobbes (< 20)
Submitted January 11, 2010

Amylin, where to begin.How about with their flagship product Byetta. Its an injection to treat diabetes that just can't capture enough market to make AMLN profitable. Management is doing a poor job. Things are so bad they recently lost a proxy fight… More

2 Comments | Reply | Report this Post
AMLN VS S&P 500 (SPY)

Fools bullish on AMLN are also bullish on:

Fools bearish on AMLN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AMLN.

Recs

0
Member Avatar acts20 (88.54) Submitted: 1/30/2012 4:43:04 PM : Outperform Start Price: $14.40 AMLN Score: +15.87

just going on buy out rumors,

Report this Post Add Comment | Reply | Permalink

Recs

1
Member Avatar geomedf (61.34) Submitted: 1/27/2012 3:47:59 PM : Outperform Start Price: $12.14 AMLN Score: +37.79

Succeeded in their third attempt to gain U.S. clearance for Bydureon, a once-weekly version of Amylin’s diabetes shot.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar PharmaEQ2xBeta (52.64) Submitted: 1/8/2012 12:58:23 PM : Underperform Start Price: $11.00 AMLN Score: -49.25

FDA doesn't approve convenience....

Report this Post Add Comment | Reply | Permalink
View All 91 Pitches »

Leaderboard

Find the members with the highest scoring picks in AMLN.

Score Leader

EmmyKaye

EmmyKaye (72.75) Score: +125.88

The Score Leader is the player with the highest score across all their picks in AMLN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
teamtec 91.67 11/24/2008 Outperform 1Y $6.09 +179.97% +69.09% +110.88 0 Comment
embodiedheart 84.47 12/2/2008 Outperform 5Y $6.26 +172.36% +63.48% +108.88 0 Comment
ajsiegel 96.74 12/3/2008 Outperform 1Y $6.35 +168.35% +67.04% +101.31 0 Comment
MustangMaggie < 20 10/3/2011 Outperform 3Y $8.72 +95.53% +20.63% +74.90 0 Comment
MudgieBoy 35.41 8/28/2006 Underperform 1Y $45.15 -62.24% +11.29% +73.52 1 Comment
GimmeGoldSlv < 20 11/12/2008 Outperform NS $7.39 +130.72% +60.42% +70.30 0 Comment
massoudb 94.59 9/20/2006 Underperform 3W $44.36 -61.56% +8.64% +70.20 0 Comment
Gr8Vette 72.28 9/15/2006 Underperform 5Y $44.75 -61.90% +8.30% +70.20 1 Comment
portefeuille3 99.68 10/3/2011 Outperform 3W $9.01 +89.34% +19.80% +69.54 0 Comment
ina1fool < 20 9/27/2006 Underperform 3W $43.96 -61.21% +7.69% +68.90 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackMKMPartners 97.33 1/11/2012 Underperform NS $10.92 +56.14% +4.90% -51.24 0 Comment
TrackRodmanRen < 20 1/5/2012 Underperform NS $10.94 +55.85% +6.57% -49.28 0 Comment
trackglobalhunte 67.21 12/7/2011 Outperform NS $10.99 +55.14% +7.57% +47.58 0 Comment
TrackRWBaird 90.46 11/14/2011 Outperform NS $10.29 +65.69% +7.27% +58.43 0 Comment
tracksummerstree 73.73 10/20/2011 Outperform NS $11.23 +51.83% +11.47% +40.35 0 Comment
TrackGoldmanSach 71.30 2/9/2011 Underperform 5Y $15.85 +7.57% +2.38% -5.19 1 Comment
TrackJimCramer 78.02 10/14/2010 Outperform 3W $21.17 -19.46% +15.24% -34.70 0 Comment
TrackDeutscheSec 92.40 9/24/2010 Outperform NS $21.18 -46.84% +2.98% -49.81 10/20/2010 @ $11.26 0 Comment
TrackCarisandCo 88.55 7/14/2010 Outperform NS $18.99 -45.39% +7.73% -53.12 10/20/2010 @ $10.37 0 Comment
trackmerriman 70.87 3/11/2010 Outperform NS $21.33 -20.07% +18.01% -38.08 0 Comment
TrackCitigroup 93.11 3/4/2010 Outperform NS $19.21 -11.24% +20.37% -31.62 0 Comment
TrackJefferies 86.14 3/4/2010 Outperform NS $19.21 -11.24% +20.37% -31.62 0 Comment
TrackCreditSuiss 93.26 3/4/2010 Outperform NS $19.21 -11.24% +20.37% -31.62 0 Comment
TrackJesupLamont 55.82 3/3/2010 Outperform NS $20.11 -15.22% +20.33% -35.55 0 Comment
TrackBarclaysCap 93.26 11/25/2009 Outperform NS $13.36 +27.62% +21.95% +5.67 0 Comment
TrackCanaccord 90.33 1/28/2009 Underperform NS $10.80 +57.87% +59.44% +1.57 0 Comment
TrackJimCramer 78.02 10/23/2008 Underperform 3W $11.34 +86.68% +28.11% -58.58 10/14/2010 @ $21.17 0 Comment
TrackLazardCapit 78.99 9/2/2008 Outperform NS $22.40 -23.88% +7.34% -31.22 0 Comment
TrackSoleil 95.78 8/27/2008 Underperform NS $23.81 -28.39% +9.49% +37.89 0 Comment
TrackIcahn 67.23 5/29/2008 Outperform 1Y $31.68 -46.18% +0.97% -47.15 5 Comments
TrackBMOCapital 89.34 4/22/2008 Underperform NS $27.41 -37.80% +1.68% +39.47 0 Comment
TrackCanaccord 90.33 2/12/2008 Underperform NS $30.04 -45.24% -21.64% +23.60 10/7/2008 @ $16.45 0 Comment
TrackRWBaird 90.46 1/15/2008 Outperform NS $35.50 -37.38% -8.56% -28.82 8/27/2008 @ $22.23 0 Comment
TrackZacks 70.75 12/13/2007 Underperform 3M $38.87 -65.73% -33.71% +32.02 10/20/2008 @ $13.32 1 Comment
TrackLehmanBros 88.86 11/1/2007 Underperform NS $44.00 -28.98% -9.36% +19.62 5/28/2008 @ $31.25 0 Comment
TrackEdwardOwens 98.63 9/30/2007 Outperform NS $50.00 -65.90% -7.05% -58.85 2 Comments
TrackJefferies 86.14 9/26/2007 Outperform NS $49.99 -45.69% -10.14% -35.55 6/9/2008 @ $27.15 0 Comment
TrackZacks 70.75 9/11/2007 Underperform 3M $48.72 -6.36% +1.48% +7.84 10/19/2007 @ $45.62 1 Comment
TrackLazardCapit 78.99 9/10/2007 Outperform NS $49.24 -48.80% -9.03% -39.78 3/3/2008 @ $25.21 0 Comment
TrackJimCramer 78.02 7/30/2007 Outperform 3W $47.15 -75.95% -36.81% -39.14 10/23/2008 @ $11.34 0 Comment
TrackStanfordRes 85.10 7/24/2007 Outperform NS $44.08 -34.87% -16.87% -18.00 8/19/2008 @ $28.71 0 Comment
TrackGaryBSmith 89.87 5/25/2007 Outperform 3W $44.91 -62.04% -5.66% -56.38 0 Comment
TrackWRHambrecht 82.51 3/13/2007 Outperform NS $38.19 -55.35% +2.28% -57.64 0 Comment
TrackLeerinkSwan 87.91 2/5/2007 Outperform NS $39.00 -77.26% -43.47% -33.79 4/7/2009 @ $8.87 0 Comment
TrackBroadpointAmTech 90.21 1/31/2007 Underperform NS $38.93 -56.20% +0.87% +57.07 0 Comment
TrackFBRCapitalM 84.41 1/31/2007 Outperform NS $39.05 -34.98% -10.47% -24.51 6/30/2008 @ $25.39 0 Comment
TrackLazardCapit 78.99 8/11/2006 Underperform NS $42.31 -5.32% +14.02% +19.34 4/13/2007 @ $40.06 0 Comment
TrackJimCramer 78.02 2/27/2006 Underperform 3W $43.97 +7.23% +13.48% +6.25 7/31/2007 @ $47.15 0 Comment

Featured Broker Partners